IL17 and IL23 have largely superseded TNF inhibitors in psoriasis. However, they still play a significant role in rheumatology and gastroenterology. We discuss where TNF inhibitors fit in the treatment options for psoriasis and explore TNF inhibitors and their competitors in inflammatory arthritis and inflammatory bowel disease (IBD).

Join us for a fireside chat with Dr Rod O’Keefe where he’ll share his professional journey as a dermatopathologist with us. He will be interviewed by A/Prof Chris Baker.

Join Dr Jenny Nicolopoulos and Dr Ryan De Cruz as they discuss the Annual Meeting- highlighting hidradenitis suppurativa (HS) and other key topics of interest as presented at the AAD Annual Meeting and the relevance of this information to Australian clinicians during a Q+A discussion.

Join Dr Crystal Williams as she discusses the 2023 AAD Annual Meeting- highlighting psoriasis and the relevance of this information to Australian clinicians during a Q+A discussion.

Join Dr Lena Ly as she discusses the 2023 AAD Annual Meeting- highlighting atopic dermatitis (AD), as presented at the AAD Annual Meeting and the relevance of this information to Australian clinicians during a Q+A discussion. A/Prof Aaron Robinson will chair the session.

Join Dr Ben Daniels as he presents on Metabolic Syndrome and Psoriasis and Dr Chris Anthony as he presents on the diagnosis and treatment of metabolic syndrome, including his thoughts on chronic inflammation and metabolic syndrome.